Difficulties in the treatment of recurrent juvenile laryngeal papillomatosis associated with pemphigus vulgaris

1. Gearhart PA, Randall TC, Buckley RM, Higgins RV. Human Papillomavirus (HPV). [Internet]. Medscape [updated Feb 20, 2020]. Available from: https://emedicine.medscape.com/article/219110-overview.Search in Google Scholar

2. Sarafoleanu C. Tumorile benigne ale laringelui. In: Popescu I, Ciuce C (eds); Sarafoleanu C (coord). Tratat de chirurgie. Editia a II-a. Vol I.: Otorinolaringologie si chirurgie cervico-faciala. Editura Academiei Romane, Bucuresti; 2012, p.199–217.Search in Google Scholar

3. Gheorghe DC. Patologia laringiana pediatrica. In: Popescu I, Ciuce C (eds); Sarafoleanu C (coord). Tratat de chirurgie. Editia a II-a. Vol I.: Otorinolaringologie si chirurgie cervico-faciala. Editura Academiei Romane, Bucuresti; 2012, p.568–601.Search in Google Scholar

4. McCane DJ. Papillomaviruses. In: Zuckermann AJ, Banatvala JE, Pattison JR (eds). Principles and practice of clinical virology. Fourth Edition. John Wiley & Sons Ltd; 2000, p.607–18. DOI: 10.1002/0470842474.ch22.10.1002/0470842474.ch22Search in Google Scholar

5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27.10.1016/j.virol.2004.03.033Search in Google Scholar

6. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12):1386–91. DOI: 10.1001/archotol.1995.Search in Google Scholar

7. Chow VT, Leong PWF. Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S. J Gen Virol. 1999;80(Pt 11):2923–9. DOI: 10.1099/0022-1317-80-11-2923.10.1099/0022-1317-80-11-2923Search in Google Scholar

8. Farmer AD, Calef CE, Millman K, Myers GL. The human papillomavirus database. J Biomed Sci. 1995;2(2):90–104.10.1007/BF02253061Search in Google Scholar

9. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.10.1056/NEJMoa021641Search in Google Scholar

10. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110(5):525–41.10.1042/CS20050369Search in Google Scholar

11. Hebner CM, Laimins LA. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol. 2006;16(2):83–97.10.1002/rmv.488Search in Google Scholar

12. Durst M, Kleinheinz A, Hotz M, Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol. 1985;66(Pt 7):1515–22.10.1099/0022-1317-66-7-1515Search in Google Scholar

13. Lehoux M, D’Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced caricnogenesis. Public Health Genomics. 2009;12(5–6):268–80. DOI: 10.1159/000214918.10.1159/000214918Search in Google Scholar

14. Hoory T, Monie A, Gravitt P, Wu TC. Molecular epidemiology of human papillomavirus. J Formos Med Assoc. 2008;107(3):198–217. DOI: 10.1016/S0929-6646(08)60138-2.10.1016/S0929-6646(08)60138-2Search in Google Scholar

15. Egawa K. Do human papillomaviruses target epidermal stem cells? Dermatology. 2003;207(3):251–4. DOI: 10.1159/000073085.10.1159/00007308514571065Search in Google Scholar

16. Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J. 2012;6:198–203. DOI: 10.2174/1874357901206010198.10.2174/1874357901206010198354738523341855Search in Google Scholar

17. Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropism, and the development of neoplasia. Viruses. 2015;7(7):386–90. DOI: 10.3390/v7072802.10.3390/v7072802451713126193301Search in Google Scholar

18. Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, et al. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol. 2004;65(8):773–82. DOI: 10.1016/j.humimm.2004.05.014.10.1016/j.humimm.2004.05.01415336778Search in Google Scholar

19. Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, et al. HLA class II polymorphism amd susceptibility to recurrent respiratory papillomatosis. J Virol. 2003;77(3):1927–39. DOI: 10.1128/JVI.77.3.1927-1939.2003.10.1128/JVI.77.3.1927-1939.2003Search in Google Scholar

20. Snowden RT, Thomson J, Horwitz E, Stocks RM. The prediction value of serum interleukins in recurrent respiratory papillomatosis: a preliminary study. Laryngoscope. 2001;111(3):404–8.10.1097/00005537-200103000-0000711224768Search in Google Scholar

21. Williams OM, Hart KW, Wang ECY, Geller CM. Analysis of CD4+ T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types. J Virol. 2002;76(15):7418–29. DOI: 10.1128/JVI.76.15.7418-7429.2002.10.1128/JVI.76.15.7418-7429.2002Search in Google Scholar

22. Hatam LJ, DeVoti JA, Rosenthal DW, Lam F, Abramson AL, Steinberg BM, et al. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res. 2012;18(7):1925–35.10.1158/1078-0432.CCR-11-2941331985122322668Search in Google Scholar

23. Ahn J, Bishop JA, Roden RBS, Allen CT, Best SRA. The PD-1and PD-L1 pathway in recurrent respiratory papillomatosis. Laryngoscope. 2018;128(1):E27–32. DOI: 10.1002/lary.26847.10.1002/lary.26847577144128940446Search in Google Scholar

24. Escobedo AR, Santillana KMS, Gonzalez JLT. Recurrent respiratory papillomatosis: review and treatment update. J Otolaryngol Rhinol. 2018;4:040. DOI: 10.23937/2572-4193.1510040.10.23937/2572-4193.1510040Search in Google Scholar

25. Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2004;68(12):1493–8.10.1016/j.ijporl.2004.06.00715533560Search in Google Scholar

26. Ivancic R, Iqbal H, deSilva B, Pan Q, Matrka L. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018;3(1):22–34. DOI: 10.1002/lio2.132.10.1002/lio2.132582410629492465Search in Google Scholar

27. Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, et al. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS. 2010;118(6–7):455–70. DOI: 10.1111/j.1600-0463.2010.02617.x.10.1111/j.1600-0463.2010.02617.x290966520553528Search in Google Scholar

28. DeVoti J, Hatam L, Lucs A, Afzal A, Abramson A, Steinberg B, et al. Decreased Langerhans cell responses to IL-36gamma: altered innate immunity in patients with recurrent respiratory papillomatosis. Mol Med. 2014;20:372–80. DOI: 10.2119/molmed.2014.00098.10.2119/molmed.2014.00098415383824950037Search in Google Scholar

29. Rhea WG Jr, Bourgeois BM, Sewell DR. Condyloma acuminata: a fatal disease? Am Surg. 1998;64(11):1082–7.Search in Google Scholar

30. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1–9.10.1016/j.jaut.2007.05.002271701517582741Search in Google Scholar

31. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3–4):197–207. DOI: 10.1016/j.jaut.2009.09.008.10.1016/j.jaut.2009.09.008278342219819109Search in Google Scholar

32. Chandrashekara S. The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review. Indian J Pharmacol. 2012;44(6):665–71. DOI: 10.4103/0253-7613.103235.10.4103/0253-7613.103235352348923248391Search in Google Scholar

33. Rosenblum MD, Gratz IK, Paw JS, Abbas AK. Treating human autoimmunity: current practice and future prospects. Sci Transl Med. 2012;4(125):125sr1. DOI: 10.1126/scitranslmed.3003504.10.1126/scitranslmed.3003504406198022422994Search in Google Scholar

34. Hall BM. Corticosteroids in autoimmune diseases. Aust Prescr. 1999;22:9–11. DOI: 10.18773/austprescr.1999.008.10.18773/austprescr.1999.008Search in Google Scholar

35. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Enlg J Med. 1995;333(15):958–63.10.1056/NEJM1995101233315027666914Search in Google Scholar

36. de Winter BCM, van Gelder T. Therapeutic drug monitoring for mycophenolic acid in patients with autoimmune disease. Nephrol Dial Transplant. 2008;23(11):3386–8. DOI: 10.1093/ndt/gfn497.10.1093/ndt/gfn49718780901Search in Google Scholar

37. Zeina B, Sakka N, Mansoor S. Pemphigus vulgaris. [Internet]. Medscape [updated Jun 14,2018]. Available online: https://emedicine.medscape.com/article/1064187-overview#a6.Search in Google Scholar

38. Fitzpatrick RE, Newcomer VD. The correlation of disease activity and antibody titers in pemphigus. Arch Dermatol. 1980;116(3):285–90.10.1001/archderm.1980.01640270045011Search in Google Scholar

39. Lombardi ML, Mercuro O, Ruocco V, Lo Schiavo A, Lombari V, Guerrera V, et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol. 1999;113(1):107–10.10.1046/j.1523-1747.1999.00626.x10417627Search in Google Scholar

40. Heelan K, Al-Mohammedi F, Smith MJ, Knowles S, Lansang P, Walsh S, et al. Durable remission of pemphigus with fixed-dose rituximab protocol. JAMA Dermatol. 2014;150(7):703–8. DOI: 10.1001/jamadermatol.2013.6739.10.1001/jamadermatol.2013.673924500264Search in Google Scholar

41. Wang Y, Shang Q, Xu W, Di L, Gu H, Wei L. Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein. Diagn Pathol. 2014;9:101. DOI: 10.1186/1746-1596-9-101.10.1186/1746-1596-9-101409914624884993Search in Google Scholar

42. Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, Schmidt J, et al. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett. 2014;8(5):1912–8. DOI: 10.3892/ol.2014.248610.3892/ol.2014.2486418657825289079Search in Google Scholar